0001421642-19-000002.txt : 20190910 0001421642-19-000002.hdr.sgml : 20190910 20190910092440 ACCESSION NUMBER: 0001421642-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190910 DATE AS OF CHANGE: 20190910 EFFECTIVENESS DATE: 20190910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICO THERAPEUTICS INC CENTRAL INDEX KEY: 0001421642 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-348370 FILM NUMBER: 191084395 BUSINESS ADDRESS: STREET 1: 760-777 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6Z 1S4 BUSINESS PHONE: 604-602-9414 MAIL ADDRESS: STREET 1: 760-777 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6Z 1S4 D 1 primary_doc.xml X0708 D LIVE 0001421642 ICO THERAPEUTICS INC 777 HORNBY STREET 6TH FLOOR VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 604-657-3882 BRITISH COLUMBIA, CANADA BEANSTALK CAPITAL LTD. None Corporation true ANDREW RAE 777 HORNBY STREET 6TH FLOOR VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Executive Officer Director SUSAN KOPPY 777 HORNBY STREET 6TH FLOOR VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director MICHAEL LIGGETT 777 HORNBY STREET 6TH FLOOR VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Executive Officer Director WILLIAM JAROSZ 777 HORNBY STREET 6TH FLOOR VANCOUVER A1 BRITISH COLUMBIA, CANADA V6Z 1S4 Director Biotechnology No Revenues 06b false 2019-08-19 true true true true true Each unit is comprised of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of $0.075 per share for a period of 36 months. false 0 2511657 187999 2323658 The additional $2,323,658.00 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. U.S. dollar amounts are based on the Bank of Canada average rate of exchange reported on 8/19/2019, which was CDN$1.3298=USD$1.00. false 1 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false ICO THERAPEUTICS INC ANDREW RAE ANDREW RAE CEO, PRESIDENT AND DIRECTOR 2019-09-06